NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT05358548 2024-04-10ATATcH Alternating Treatment Plans for Advanced CancerRutgers, The State University of New JerseyPhase 2 Recruiting150 enrolled
NCT02897375 2023-10-10Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsEmory UniversityPhase 1 Completed71 enrolled
NCT00003657 2017-01-20High-dose ICE With AmifostineDana-Farber Cancer InstitutePhase 2 Completed24 enrolled